Disposition of propranolol isomers in mice-Reference-Cited by-同舟云学术

Disposition of propranolol isomers in mice

Published:1976-11 Issue:1 Volume:40 Page:93-100
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Levy Aharon,Ngai S.H.,Donald Finck A.,Kawashima Koichiro,Spector Sydney

Publisher

Elsevier BV

Subject

Pharmacology

Reference14 articles.

1. Control of pineal N-acetylserotonin by a beta adrenergic receptor;Brownstein;Mol. Pharmacol.,1973

2. The disposition of propranolol. III. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat;Evans;J. Pharmacol. Exptl. Therap.,1973

3. Pharmacokinetics of dextro-laevo- and racemic propranolol in man;George;European J. Clin. Pharmacol.,1972

4. Studies on the absorption, distribution and excretion of propranolol in rat, dog, and monkey;Hayes;J. Pharmacol. Exptl. Therap.,1971

5. Stereospecific radioimmunoassay for propranolol isomers;Kawashima;J. Pharmacol. Exptl. Therap.,1976

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human CYP2D6 varies across the estrous cycle in brains of transgenic mice altering drug response;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-12

2. Adrenergic receptor system as a pharmacological target in the treatment of epilepsy (Review);Medicine International;2024-02-27

3. Human CYP2D6 in the Brain Is Protective Against Harmine-Induced Neurotoxicity: Evidence from Humanized CYP2D6 Transgenic Mice;Molecular Neurobiology;2020-08-06

4. Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice;Molecular Neurobiology;2020-03-18

5. Propranolol is a mechanism‐based inhibitor of CYP2D and CYP2D6 in humanized CYP2D6‐transgenic mice: Effects on activity and drug responses;British Journal of Pharmacology;2020-01-06